TAK-071 for Mild Cognitive Impairment and Mild Alzheimer's Disease

Language
Undefined

Purpose: To assess the safety, tolerability, and pharmacokinetics of the experimental drug TAK-071 for mild cognitive impairment and mild Alzheimer's disease.

Source: Alzheimers Clinical Trials - June 22, 2016 Category: Geriatrics Authors: chirschman Source Type: clinical trials